abstract |
Methods for treating bladder cancer comprising intravesicular administration of a stabilized pharmaceutical formulation comprising 5 -(1-aziridinyl)-3-(hydroxymethyl)- 2 -[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9). More specifically, the stabilized pharmaceutical formulation is instilled in the bladder for a time sufficient to treat the cancer. |